Furthermore, both stratification and multivariate analyses for controlling potential confounders in our study revealed no significant association between anti-VEGF therapy and neurodevelopmental delay in motor, cognitive, and language domains. The gene discussed is VEGFA; the disease is Neurodevelopmental delay.